Center-Authored Papers

Filters: Author is Arai, Sally  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME et al..  2015.  Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study. The Lancet Haematology. 2(9):e367-e375. Abstract
Arai S, Jagasia M, Storer BE, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers MED, Martin PJ et al..  2011.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.. Blood. 118(15):4242-4249. Abstract
Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia M, Mayer SA et al..  2015.  A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M et al..  2015.  Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):266-74. Abstract
Arora M, Cutler CS, Jagasia MH, Pidala J, Chai X, Martin PJ, Flowers MED, Inamoto Y, Chen GL, Wood WA et al..  2015.  Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
C
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
H
Holtan SG, Khera N, Levine JE, Chai X, Storer B, Liu HD, Inamoto Y, Chen GL, Mayer S, Arora M et al..  2016.  Late acute graft versus host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.. Blood. 128(19):2350-2358. Abstract
I
Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers MED, Palmer J, Arai S, Jacobsohn D, Cutler C et al..  2014.  Joint and fascia manifestations in chronic graft-versus-host disease and their assessment.. Arthritis and rheumatism. 66(4):1044-52. Abstract
Inamoto Y, Martin PJ, Storer BE, Palmer J, Weisdorf D, Pidala J, Flowers MED, Arora M, Jagasia M, Arai S et al..  2014.  Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.. Haematologica. 99(10):1618-23. Abstract
J
Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, Arai S, Arora M, Jagasia M, Cutler C et al..  2012.  Correlation between NIH composite skin score, patient reported skin score and outcome: results from the Chronic GVHD Consortium.. Blood. 120(13):2545-52. Abstract
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng G-S et al..  2015.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(3):389-401.e1. Abstract
L
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
M
Martin PJ, Storer BE, Inamoto Y, Flowers MED, Carpenter PA, Pidala J, Palmer J, Arora M, Jagasia M, Arai S et al..  2017.  An endpoint associated with clinical benefit after initial treatment for chronic graft-versus-host disease.. Blood. Abstract
P
Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA et al..  2013.  Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Palmer J, Chai X, Martin PJ, Weisdorf D, Inamoto Y, Pidala J, Jagasia M, Pavletic S, Cutler C, Vogelsang G et al..  2015.  Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.. Haematologica. 100(5):690-5. Abstract
Pereira S, Vayntrub T, Hiraki DD, Cherry AM, Arai S, Dvorak CC, Grumet CF.  2011.  Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants.. Human immunology. 72(6):503-9. Abstract
Pidala J, Vogelsang G, Martin P, Chai X, Storer B, Pavletic S, Weisdorf DJ, Jagasia M, Cutler C, Palmer J et al..  2012.  Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.. Haematologica. 97(3):451-8. Abstract
Pidala J, Kurland BF, Chai X, Majhail N, Weisdorf DJ, Pavletic S, Cutler C, Jacobsohn D, Palmer J, Arai S et al..  2011.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.. Blood. 117(17):4651-7. Abstract
R
Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL et al..  2016.  Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.. Blood. Abstract
T
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
Y
Yuan A, Chai X, Martins F, Arai S, Arora M, Correa ME, Pidala J, Cutler C, Lee SJ, Treister NS.  2015.  Oral chronic GVHD outcomes and resource utilization: a subanalysis from the chronic GVHD consortium.. Oral diseases. Abstract